Cardiovascular risk assessment in children with chronic kidney disease

Rukshana Shroff, Arianna Dégi, Andrea Kerti, Éva Kis, Orsolya Cseprekál, Kálmán Tory, Attila J. Szabó, George S. Reusz

Research output: Contribution to journalReview article

27 Citations (Scopus)


Chronic kidney disease (CKD) is a major factor contributing to cardiovascular (CV) morbidity and mortality with the highest risk in patients on dialysis. An estimation of CV risk is important not only to identify potential modifiable risk factors but also to evaluate the effect of treatments aimed to reduce the risk. Non-invasive methods of measuring vascular changes and circulating biomarkers are available to assess the presence and severity of cardiovascular damage. These include measures of structural (carotid intima-media thickness and coronary artery calcification score) and functional (aortic pulse wave velocity, 24-h ambulatory blood pressure monitoring, ambulatory arterial stiffness index, heart rate variability and flow-mediated dilatation) changes in the vessel wall. In addition, a number of circulating biomarkers of vascular damage and its progression have been studied. Many of these tests are well validated as surrogate markers of future cardiovascular events and death in adult CKD patients, but need technical adaptation, standardization and validation for use in children. With our current state of knowledge, these are best reserved for research studies and scarce clinical resources may be better utilized for preventative strategies to reduce the modifiable risk factors for calcification from early CKD stages.

Original languageEnglish
Pages (from-to)875-884
Number of pages10
JournalPediatric Nephrology
Issue number6
Publication statusPublished - Jun 1 2013



  • Biomarkers
  • Cardiovascular disease
  • Carotid intima-media thickness
  • Chronic kidney disease
  • Pulse wave velocity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Nephrology

Cite this